Yes, I do. And you say they haven't been transparent, but they're just not flooding with PR every other day.
Here's why they ARE being as transparent as they feel they're legally allowed to be:
1. They put out PR and file an 8K with that PR AFTER they've made progress. They don't put out a PR stating "Here is what we're going to do". This is better they don't because they've obviously realized that there few in numbers and priorities may change on a drop of a hat.
2. They've put into mid Q releases that they've converted shares to either retire debt or to function day to day. I do not believe they can legally release this information prior to doing so.
3. They aren't releasing numbers of doctors to be signed prior to them able to be active. This is good because the speculation on revenue is our fault then, and NOT theirs because they're hyping the number that are active.
4. They've NOT released specifics on Cav Int. Contracts because they're not finalized. I've wondered about that, and the one translated article proves there's still questions. How much the kits will have to cost the Russians, and if they may actually be produced in Russia in the future. This, again, keeps from there being a baseless pump that may cause EVEN LARGER losses than by not releasing "potential profit".
5. They AREN'T paying for national exposure that is only going to kick the stock price short term, but then tank it because they had to dilute shares to pay for it.
6. They DON'T pump on specifics of what they think they're going to do, which they then pivot on because bigger better priorities pop up. How many OTC stocks state they're going to have revenue from a contract in Qx, and don't because of what ever reason. What happens to this stocks SP... IT TANKS, because of what that company has done.
But the reality is this:
1. We got a taste of a HUGE run that showed many of us HUGE profits. Then we got spanked by reality again.
2. This stock is even from the first purchase I made in June.
3. It's only been 6 months since the first doctors started to sign up after May AUA.
4. Plans for US capitalization of the product was deleted because another country needing MORE TREATMENT than the US called and said we'll pay come inject us. And one of the top ranked and connected doc in this country said he's going to try and get it covered by national insurance!
5. 6 months is nothing in terms of taking a product to market.
Outside of the normal OTC impatients, what is this company not doing right? What has been wrong compared to anything that other legitimate corporations do? When does Merk, Roche, BMY release info before they have verified information. Hell today Roche announced they stopped in process clinical trials this quarter, and nobody knew it until they saw it in the presentation.
Maybe we want more info because we don't like being red, but maybe the company realizes their limitations and don't want to pump what they can't guarantee they can provide with their currently limited resources.
I could understand if the company was run by people who have proven to be not so credible, but the credibility of these execs are currently proven and pristine.
I just don't understand the expectations.
AI
